Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Non-oncology Biopharmaceuticals Market Size Growth Rate by Type (2014-2025) 1.4.2 Biologics 1.4.3 Biosimilars 1.5 Market by Application 1.5.1 Global Non-oncology Biopharmaceuticals Market Share by Application (2014-2025) 1.5.2 Immunology 1.5.3 Endocrinology 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Non-oncology Biopharmaceuticals Market Size 2.2 Non-oncology Biopharmaceuticals Growth Trends by Regions 2.2.1 Non-oncology Biopharmaceuticals Market Size by Regions (2014-2025) 2.2.2 Non-oncology Biopharmaceuticals Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 3 Market Share by Key Players 3.1 Non-oncology Biopharmaceuticals Market Size by by Players 3.1.1 Global Non-oncology Biopharmaceuticals Revenue by by Players (2014-2019) 3.1.2 Global Non-oncology Biopharmaceuticals Revenue Market Share by by Players (2014-2019) 3.1.3 Global Non-oncology Biopharmaceuticals Market Concentration Ratio (CR5 and HHI) 3.2 Non-oncology Biopharmaceuticals Key Players Head office and Area Served 3.3 Key Players Non-oncology Biopharmaceuticals Product/Solution/Service 3.4 Date of Enter into Non-oncology Biopharmaceuticals Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Non-oncology Biopharmaceuticals Market Size by Type (2014-2019) 4.2 Global Non-oncology Biopharmaceuticals Market Size by Application (2014-2019) 5 United States 5.1 United States Non-oncology Biopharmaceuticals Market Size (2014-2019) 5.2 Non-oncology Biopharmaceuticals Key Players in United States 5.3 United States Non-oncology Biopharmaceuticals Market Size by Type 5.4 United States Non-oncology Biopharmaceuticals Market Size by Application 6 Europe 6.1 Europe Non-oncology Biopharmaceuticals Market Size (2014-2019) 6.2 Non-oncology Biopharmaceuticals Key Players in Europe 6.3 Europe Non-oncology Biopharmaceuticals Market Size by Type 6.4 Europe Non-oncology Biopharmaceuticals Market Size by Application 7 China 7.1 China Non-oncology Biopharmaceuticals Market Size (2014-2019) 7.2 Non-oncology Biopharmaceuticals Key Players in China 7.3 China Non-oncology Biopharmaceuticals Market Size by Type 7.4 China Non-oncology Biopharmaceuticals Market Size by Application 8 Japan 8.1 Japan Non-oncology Biopharmaceuticals Market Size (2014-2019) 8.2 Non-oncology Biopharmaceuticals Key Players in Japan 8.3 Japan Non-oncology Biopharmaceuticals Market Size by Type 8.4 Japan Non-oncology Biopharmaceuticals Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Non-oncology Biopharmaceuticals Market Size (2014-2019) 9.2 Non-oncology Biopharmaceuticals Key Players in Southeast Asia 9.3 Southeast Asia Non-oncology Biopharmaceuticals Market Size by Type 9.4 Southeast Asia Non-oncology Biopharmaceuticals Market Size by Application 10 India 10.1 India Non-oncology Biopharmaceuticals Market Size (2014-2019) 10.2 Non-oncology Biopharmaceuticals Key Players in India 10.3 India Non-oncology Biopharmaceuticals Market Size by Type 10.4 India Non-oncology Biopharmaceuticals Market Size by Application 11 Central & South America 11.1 Central & South America Non-oncology Biopharmaceuticals Market Size (2014-2019) 11.2 Non-oncology Biopharmaceuticals Key Players in Central & South America 11.3 Central & South America Non-oncology Biopharmaceuticals Market Size by Type 11.4 Central & South America Non-oncology Biopharmaceuticals Market Size by Application 12 International Players Profiles 12.1 Roche 12.1.1 Roche Company Details 12.1.2 Company Description and Business Overview 12.1.3 Non-oncology Biopharmaceuticals Introduction 12.1.4 Roche Revenue in Non-oncology Biopharmaceuticals Business (2014-2019) 12.1.5 Roche Recent Development 12.2 Sanofi 12.2.1 Sanofi Company Details 12.2.2 Company Description and Business Overview 12.2.3 Non-oncology Biopharmaceuticals Introduction 12.2.4 Sanofi Revenue in Non-oncology Biopharmaceuticals Business (2014-2019) 12.2.5 Sanofi Recent Development 12.3 Johnson & Johnson 12.3.1 Johnson & Johnson Company Details 12.3.2 Company Description and Business Overview 12.3.3 Non-oncology Biopharmaceuticals Introduction 12.3.4 Johnson & Johnson Revenue in Non-oncology Biopharmaceuticals Business (2014-2019) 12.3.5 Johnson & Johnson Recent Development 12.4 Pfizer 12.4.1 Pfizer Company Details 12.4.2 Company Description and Business Overview 12.4.3 Non-oncology Biopharmaceuticals Introduction 12.4.4 Pfizer Revenue in Non-oncology Biopharmaceuticals Business (2014-2019) 12.4.5 Pfizer Recent Development 12.5 Novo Nordisk 12.5.1 Novo Nordisk Company Details 12.5.2 Company Description and Business Overview 12.5.3 Non-oncology Biopharmaceuticals Introduction 12.5.4 Novo Nordisk Revenue in Non-oncology Biopharmaceuticals Business (2014-2019) 12.5.5 Novo Nordisk Recent Development 12.6 Novartis 12.6.1 Novartis Company Details 12.6.2 Company Description and Business Overview 12.6.3 Non-oncology Biopharmaceuticals Introduction 12.6.4 Novartis Revenue in Non-oncology Biopharmaceuticals Business (2014-2019) 12.6.5 Novartis Recent Development 12.7 Merck 12.7.1 Merck Company Details 12.7.2 Company Description and Business Overview 12.7.3 Non-oncology Biopharmaceuticals Introduction 12.7.4 Merck Revenue in Non-oncology Biopharmaceuticals Business (2014-2019) 12.7.5 Merck Recent Development 12.8 Teva 12.8.1 Teva Company Details 12.8.2 Company Description and Business Overview 12.8.3 Non-oncology Biopharmaceuticals Introduction 12.8.4 Teva Revenue in Non-oncology Biopharmaceuticals Business (2014-2019) 12.8.5 Teva Recent Development 12.9 Eli Lilly 12.9.1 Eli Lilly Company Details 12.9.2 Company Description and Business Overview 12.9.3 Non-oncology Biopharmaceuticals Introduction 12.9.4 Eli Lilly Revenue in Non-oncology Biopharmaceuticals Business (2014-2019) 12.9.5 Eli Lilly Recent Development 12.10 Bristol-Myers Squibb 12.10.1 Bristol-Myers Squibb Company Details 12.10.2 Company Description and Business Overview 12.10.3 Non-oncology Biopharmaceuticals Introduction 12.10.4 Bristol-Myers Squibb Revenue in Non-oncology Biopharmaceuticals Business (2014-2019) 12.10.5 Bristol-Myers Squibb Recent Development 12.11 GlaxoSmithKline 12.12 UCB Pharma 12.13 Amgen 12.14 AbbVie 12.15 Takeda 12.16 AstraZeneca 12.17 Mylan 12.18 LEO Pharma 12.19 Boehringer Ingelheim 12.20 Alexion Pharmaceuticals 12.21 Elusys Therapeutics 12.22 Swedish Orphan Biovitrum 12.23 Biogen 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Non-oncology Biopharmaceuticals Key Market Segments Table Key Players Non-oncology Biopharmaceuticals Covered Table Global Non-oncology Biopharmaceuticals Market Size Growth Rate by Type 2019-2025 (Million US$) Figure Global Non-oncology Biopharmaceuticals Market Share by TypeType in 2018 & 2025 Figure Biologics Figures Table Key Players of Biologics Figure Biosimilars Figures Table Key Players of Biosimilars Table Global Non-oncology Biopharmaceuticals Market Size Growth by Application 2019-2025 (Million US$) Figure Global Non-oncology Biopharmaceuticals Market Share by Application in 2018 & 2025 Figure Immunology Case Studies Figure Endocrinology Case Studies Figure Others Case Studies Figure Non-oncology Biopharmaceuticals Report Years Considered Table Global Non-oncology Biopharmaceuticals Market Size 2014-2025 (Million US$) Figure Global Non-oncology Biopharmaceuticals Market Size and Growth Rate 2014-2025 (Million US$) Table Global Non-oncology Biopharmaceuticals Market Size by Regions 2019-2025 (Million US$) Table Global Non-oncology Biopharmaceuticals Market Size by Regions 2019-2025 (Million US$) Table Global Non-oncology Biopharmaceuticals Market Share by Regions 2014-2019 Figure Global Non-oncology Biopharmaceuticals Market Share by Regions 2014-2019 Figure Global Non-oncology Biopharmaceuticals Market Share by Regions 2018 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure PORTER'S FIVE FORCES ANALYSIS Table Global Non-oncology Biopharmaceuticals Revenue by by Players (2014-2019) (Million US$) Table Global Non-oncology Biopharmaceuticals Market Share by by Players (2014-2019) Figure Global Non-oncology Biopharmaceuticals Market Share by by Players in 2018 Table Global Non-oncology Biopharmaceuticals by Players Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Non-oncology Biopharmaceuticals Product/Solution/Service Table Date of Enter into Non-oncology Biopharmaceuticals Market Table Mergers & Acquisitions, Expansion Plans Table Global Non-oncology Biopharmaceuticals Market Size by Type (2014-2019) (Million US$) Table Global Non-oncology Biopharmaceuticals Market Size Share by Type (2014-2019) Figure Global Non-oncology Biopharmaceuticals Market Size Market Share by Type (2014-2019) Table Global Non-oncology Biopharmaceuticals Market Size by Application (2014-2019) (Million US$) Table Global Non-oncology Biopharmaceuticals Market Size Share by Application (2014-2019) Figure Global Non-oncology Biopharmaceuticals Market Size Market Share by Application (2014-2019) Figure Global Non-oncology Biopharmaceuticals Revenue Market Share by Application in 2018 Figure United States Non-oncology Biopharmaceuticals Market Size 2014-2019 (Million US$) Table United States Key Players Non-oncology Biopharmaceuticals Revenue (2018-2019) (Million US$) Table United States Key Players Non-oncology Biopharmaceuticals Market Share (2018-2019) Table United States Non-oncology Biopharmaceuticals Market Size by Type (2014-2019) (Million US$) Table United States Non-oncology Biopharmaceuticals Market Share by Type (2014-2019) Table United States Non-oncology Biopharmaceuticals Market Size by Application (2014-2019) (Million US$) Table United States Non-oncology Biopharmaceuticals Market Share by Application (2014-2019) Figure Europe Non-oncology Biopharmaceuticals Market Size 2014-2019 (Million US$) Table Europe Key Players Non-oncology Biopharmaceuticals Revenue (2018-2019) (Million US$) Table Europe Key Players Non-oncology Biopharmaceuticals Market Share (2018-2019) Table Europe Non-oncology Biopharmaceuticals Market Size by Type (2014-2019) (Million US$) Table Europe Non-oncology Biopharmaceuticals Market Share by Type (2014-2019) Table Europe Non-oncology Biopharmaceuticals Market Size by Application (2014-2019) (Million US$) Table Europe Non-oncology Biopharmaceuticals Market Share by Application (2014-2019) Figure China Non-oncology Biopharmaceuticals Market Size 2014-2019 (Million US$) Table China Key Players Non-oncology Biopharmaceuticals Revenue (2018-2019) (Million US$) Table China Key Players Non-oncology Biopharmaceuticals Market Share (2018-2019) Table China Non-oncology Biopharmaceuticals Market Size by Type (2014-2019) (Million US$) Table China Non-oncology Biopharmaceuticals Market Share by Type (2014-2019) Table China Non-oncology Biopharmaceuticals Market Size by Application (2014-2019) (Million US$) Table China Non-oncology Biopharmaceuticals Market Share by Application (2014-2019) Figure Japan Non-oncology Biopharmaceuticals Market Size 2014-2019 (Million US$) Table Japan Key Players Non-oncology Biopharmaceuticals Revenue (2018-2019) (Million US$) Table Japan Key Players Non-oncology Biopharmaceuticals Market Share (2018-2019) Table Japan Non-oncology Biopharmaceuticals Market Size by Type (2014-2019) (Million US$) Table Japan Non-oncology Biopharmaceuticals Market Share by Type (2014-2019) Table Japan Non-oncology Biopharmaceuticals Market Size by Application (2014-2019) (Million US$) Table Japan Non-oncology Biopharmaceuticals Market Share by Application (2014-2019) Figure Southeast Asia Non-oncology Biopharmaceuticals Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Non-oncology Biopharmaceuticals Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Non-oncology Biopharmaceuticals Market Share (2018-2019) Table Southeast Asia Non-oncology Biopharmaceuticals Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Non-oncology Biopharmaceuticals Market Share by Type (2014-2019) Table Southeast Asia Non-oncology Biopharmaceuticals Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Non-oncology Biopharmaceuticals Market Share by Application (2014-2019) Figure India Non-oncology Biopharmaceuticals Market Size 2014-2019 (Million US$) Table India Key Players Non-oncology Biopharmaceuticals Revenue (2018-2019) (Million US$) Table India Key Players Non-oncology Biopharmaceuticals Market Share (2018-2019) Table India Non-oncology Biopharmaceuticals Market Size by Type (2014-2019) (Million US$) Table India Non-oncology Biopharmaceuticals Market Share by Type (2014-2019) Table India Non-oncology Biopharmaceuticals Market Size by Application (2014-2019) (Million US$) Table India Non-oncology Biopharmaceuticals Market Share by Application (2014-2019) Figure Central & South America Non-oncology Biopharmaceuticals Market Size 2014-2019 (Million US$) Table Central & South America Key Players Non-oncology Biopharmaceuticals Revenue (2018-2019) (Million US$) Table Central & South America Key Players Non-oncology Biopharmaceuticals Market Share (2018-2019) Table Central & South America Non-oncology Biopharmaceuticals Market Size by Type (2014-2019) (Million US$) Table Central & South America Non-oncology Biopharmaceuticals Market Share by Type (2014-2019) Table Central & South America Non-oncology Biopharmaceuticals Market Size by Application (2014-2019) (Million US$) Table Central & South America Non-oncology Biopharmaceuticals Market Share by Application (2014-2019) Table Roche Company Details Table Roche Revenue in Non-oncology Biopharmaceuticals Business (2014-2019) (Million US$) Figure Roche Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2014-2019) Table Roche Recent Development Table Sanofi Company Details Table Sanofi Revenue in Non-oncology Biopharmaceuticals Business (2014-2019)(Million US$) Figure Sanofi Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2014-2019) Table Sanofi Recent Development Table Johnson & Johnson Company Details Table Johnson & Johnson Revenue in Non-oncology Biopharmaceuticals Business (2014-2019)(Million US$) Figure Johnson & Johnson Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2014-2019) Table Johnson & Johnson Recent Development Table Pfizer Company Details Table Pfizer Revenue in Non-oncology Biopharmaceuticals Business (2014-2019)(Million US$) Figure Pfizer Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2014-2019) Table Pfizer Recent Development Table Novo Nordisk Company Details Table Novo Nordisk Revenue in Non-oncology Biopharmaceuticals Business (2014-2019)(Million US$) Figure Novo Nordisk Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2014-2019) Table Novo Nordisk Recent Development Table Novartis Company Details Table Novartis Revenue in Non-oncology Biopharmaceuticals Business (2014-2019)(Million US$) Figure Novartis Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2014-2019) Table Novartis Recent Development Table Merck Company Details Table Merck Revenue in Non-oncology Biopharmaceuticals Business (2014-2019)(Million US$) Figure Merck Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2014-2019) Table Merck Recent Development Table Teva Company Details Table Teva Revenue in Non-oncology Biopharmaceuticals Business (2014-2019)(Million US$) Figure Teva Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2014-2019) Table Teva Recent Development Table Eli Lilly Company Details Table Eli Lilly Revenue in Non-oncology Biopharmaceuticals Business (2014-2019)(Million US$) Figure Eli Lilly Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2014-2019) Table Eli Lilly Recent Development Table Bristol-Myers Squibb Company Details Table Bristol-Myers Squibb Revenue in Non-oncology Biopharmaceuticals Business (2014-2019)(Million US$) Figure Bristol-Myers Squibb Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2014-2019) Table Bristol-Myers Squibb Recent Development Table GlaxoSmithKline Company Details Table UCB Pharma Company Details Table Amgen Company Details Table AbbVie Company Details Table Takeda Company Details Table AstraZeneca Company Details Table Mylan Company Details Table LEO Pharma Company Details Table Boehringer Ingelheim Company Details Table Alexion Pharmaceuticals Company Details Table Elusys Therapeutics Company Details Table Swedish Orphan Biovitrum Company Details Table Biogen Company Details Table Global Non-oncology Biopharmaceuticals Market Size by Regions (Million US$) 2019-2025 Figure Global Non-oncology Biopharmaceuticals Market Size Share by Regions (2019-2025) Figure Global Non-oncology Biopharmaceuticals Market Size Share by Regions in 2025 Figure United States Non-oncology Biopharmaceuticals Market Size Forecast (2019-2025)(Million USD) Figure Europe Non-oncology Biopharmaceuticals Market Size Forecast (2019-2025)(Million USD) Figure China Non-oncology Biopharmaceuticals Market Size Forecast (2019-2025)(Million USD) Figure Japan Non-oncology Biopharmaceuticals Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Non-oncology Biopharmaceuticals Market Size Forecast (2019-2025)(Million USD) Figure India Non-oncology Biopharmaceuticals Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Non-oncology Biopharmaceuticals Market Size Forecast (2019-2025)(Million USD) Table Global Non-oncology Biopharmaceuticals Market Size by Product (2019-2025) (Million US$) Figure Global Non-oncology Biopharmaceuticals Market Size by Product (2019-2025) Figure Global Non-oncology Biopharmaceuticals Market Size by Product in 2025 Table Global Non-oncology Biopharmaceuticals Market Size by Application (2019-2025) (Million US$) Figure Global Non-oncology Biopharmaceuticals Market Size by Application (2019-2025) Figure Global Non-oncology Biopharmaceuticals Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Roche Sanofi Johnson & Johnson Pfizer Novo Nordisk Novartis Merck Teva Eli Lilly Bristol-Myers Squibb GlaxoSmithKline UCB Pharma Amgen AbbVie Takeda AstraZeneca Mylan LEO Pharma Boehringer Ingelheim Alexion Pharmaceuticals Elusys Therapeutics Swedish Orphan Biovitrum Biogen